SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-251378
Filing Date
2017-08-08
Accepted
2017-08-08 16:23:49
Documents
57
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d425283d10q.htm 10-Q 309580
2 EX-10.1 d425283dex101.htm EX-10.1 28632
3 EX-10.2 d425283dex102.htm EX-10.2 31633
4 EX-31.1 d425283dex311.htm EX-31.1 6748
5 EX-31.2 d425283dex312.htm EX-31.2 6580
6 EX-32.1 d425283dex321.htm EX-32.1 4191
7 EX-32.2 d425283dex322.htm EX-32.2 4205
14 GRAPHIC g425283g07n05.jpg GRAPHIC 1541
  Complete submission text file 0001193125-17-251378.txt   2548514

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ccxi-20170630.xml EX-101.INS 465356
9 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20170630.xsd EX-101.SCH 34473
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20170630_cal.xml EX-101.CAL 48259
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20170630_def.xml EX-101.DEF 84617
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20170630_lab.xml EX-101.LAB 263983
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20170630_pre.xml EX-101.PRE 183780
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 171015117
SIC: 2834 Pharmaceutical Preparations